Drug recall
Premarin Tablets (conjugated estrogens tablets, USP), 0.625 mg, 5,000 tablet bottles, Rx only, Ayerst…
FDA recall event 26506 · Class III · Richmond Division of Wyeth
Key facts
| Event ID | 26506 |
|---|---|
| Recall numbers | D-299-3, D-300-3, D-301-3 |
| Recalling firm | Richmond Division of Wyeth |
| Product type | Drugs |
| Products | Premarin Tablets (conjugated estrogens tablets, USP), 0.625 mg, 5,000 tablet bottles, Rx only, Ayerst Laboratories Inc., A Wyeth-Ayerst Company, Philadelphia, PA 19101, NDC 0046-0867-95, PREMARIN tablets (conjugated estrogens tablets, USP), 0.9 mg, 100 tablet bottles, Rx only, Ayerst Laboratories Inc., A Wyeth-Ayerst Company, Philadelphia, PA 19101, NDC 0046-0864-81, Premarin Tablets (conjugated estrogens tablets, USP), 1.25 mg, 5,000 tablet bottles, Rx only, Ayerst Laboratories Inc., A Wyeth-Ayerst Company, Philadelphia, PA 19101, NDC 0046-0866-95 |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Dissolution Failure |
| Initiation date | Jun 19, 2003 |
| City | Richmond |
| Country | United States |
| FEI number | 1110584 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports